• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Scientific Publications by FDA Staff

  • Print
  • Share
  • E-mail
-

Search Publications



Fields



Centers











Starting Date


Ending Date


Order by

Entry Details

Toxicol Lett 2014 Jan 21;225(3):401-6

Circulating extracellular vesicles as a potential source of new biomarkers of drug induced liver injury.

Yang X, Weng Z, Mendrick DL, Shi Q

Abstract

Like most cell types, hepatocytes constantly produce extracellular vesicles (EVs) such as exosomes and microvesicles that are released into the circulation to transport signaling molecules and cellular waste. Circulating EVs are being vigorously explored as biomarkers of diseases and toxicities, including drug induced liver injury (DILI). Emerging data suggest that a) blood-borne EVs contain liver-specific mRNAs and microRNAs (miRNAs), b) the levels can be remarkably elevated in response to DILI, and c) the increases correlate well with classical measures of liver damage. The expression profile of mRNAs in EVs and the compartmentalization of miRNAs within EVs or other blood fractions were found to be indicative of the offending drug involved in DILI, thus providing more informative assessment of liver injury than using alanine aminotransferase (ALT) alone. EVs in the urine and cell culture medium were also found to contain proteins or mRNAs that were indicative of DILI. However, major improvements in EV isolation methods are needed for the discovery, evaluation and quantification of possible DILI biomarkers in circulating EVs.


Category: Journal Article
PubMed ID: #24462978 DOI: 10.1016/j.toxlet.2014.01.013
Includes FDA Authors from Scientific Area(s): Toxicological Research
Entry Created: 2014-01-28 Entry Last Modified: 2014-02-15
Feedback
-
-